Tabula Rasa HealthCare Reports Third Quarter 2021 Results

Go back to Tabula Rasa HealthCare Reports Third Quarter 2021 Results

Tabula Rasa Healthcare (TRHC) PT Lowered to $22 at Cantor Fitzgerald

November 5, 2021 11:59 AM EDT

Cantor Fitzgerald analyst Steven Halper lowered the price target on Tabula Rasa Healthcare (NASDAQ: TRHC) to $22.00 (from $40.00) while maintaining a Neutral rating.

The analyst commented, "We reiterate our Neutral rating on TRHC shares and lower our price target to $22 from $40. After the market... More

Tabula Rasa HealthCare (TRHC) Misses Q3 EPS

November 4, 2021 5:08 PM EDT

Tabula Rasa HealthCare (NASDAQ: TRHC) reported Q3 EPS of ($0.73), which may not compare to the analyst estimate of $0.03. Revenue for the quarter came in at $86.6 million versus the consensus estimate of $88.52 million.

For earnings history and earnings-related data on Tabula Rasa HealthCare (TRHC) click here.

... More